82 results on '"Sargent, Carey"'
Search Results
2. Picture My Gender(s): Using Interactive Media to Engage Students in Theories of Gender Construction
3. iMusic: Living and Working as Musicians in Digital Capitalism
4. PLAYING, SHOPPING, AND WORKING AS ROCK MUSICIANS: Masculinities in "De-Skilled" and "Re-Skilled" Organizations
5. Noise in action: the sonic (de)construction of art worlds
6. Novartis May Raise Public Alcon Bid
7. Movable Party: A Bicycle-powered System for Interactive Musical Performance
8. Picture My Gender(s)
9. Novartis purchase adds 2 drugs to product line; Makes third deal this week
10. Novartis, Human Genome join forces over hepatitis drug
11. Pfizer to pay up to $803M for rights to Incyte drugs
12. Generic copies of biotechnology drugs looming over market; Patents expiring for products with annual sales in the billions
13. LOCAL MUSICIANS BUILDING GLOBAL AUDIENCES
14. Roche Holding posts $2.97 billion net loss for 2002
15. Roche to purchase Disetronic, sell vitamins business
16. Serono purchases rights for drug to treat MS
17. Aventis net rises, but scales drop
18. The geneticist; when Mary-Dell Chilton began as a researcher, there was no such thing as biotechnology. Now, she's helping to define it
19. Data on Novartis's leukemia pill suggest improvement is tied to early treatment
20. Dentsply to pay $492.1 million for Dugussa AG's dental unit
21. UBS to publish preliminary earnings early
22. Ciba sidesteps price pressures as net rises 65%
23. DIY Musicians meet Web 2.0.
24. Local Musicians in the Age of Digital Reproduction.
25. Local Culture for Sale: Small Town Music Monopoly, Small Town Resistance.
26. Enacting Rock Authenticity in Music Stores.
27. Cultural Logic: Against Economic Determinism.
28. Forest Laboratories' Globe-Trotting Profits.
29. Commerzbank lifts its net income
30. Speedel makes its mark guiding drugs through testing stages: Five-year-old Swiss company thrives after pact with Novartis on blood-pressure medication
31. Roche swung to loss for 2002, cites heavy litigation charges
32. Strong currency expected to pressure Novartis results
33. Schering's menopause drug wins approval in Netherlands
34. OGS's first drug gets approval for EU market
35. Roche gets rights to some drugs from Antisoma
36. Aventis reports 21% rise in 3rd-quarter profit
37. Glaxo claims generics makers stole its secrets
38. Syngenta's profit up in 1st half on cost savings, lower taxes
39. Oxford GlycoSciences reaches marketing deal with Actelion
40. Serono posts a decline in net, lowers its full-year estimates
41. Pliva of Croatia agrees to buy a U.S. drug firm and its unit
42. Clariant has reduced its debt
43. Serono reports 5.2% increase in yearly profit
44. Schering will take a stake MorphoSys and fund research
45. BASF earnings disappoint as sales decline by 22%
46. Bayer to report weak results for third quarter
47. Serono posts sales below expectations for third quarter
48. Clariant's revenue falls on slowdown
49. Actelion nears launch of drug after U.S. regulatory action
50. Celanese again cuts earnings estimates for the full year
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.